title: [Lupus anticoagulant and Behçet's disease: increase of vascular risk?].
authors.forename: F
authors.initials: F
authors.lastname: Bonnet
authors.forename: S
authors.initials: S
authors.lastname: Debruxelles
authors.forename: L
authors.initials: L
authors.lastname: Dubourguet
authors.forename: V
authors.initials: V
authors.lastname: Guérin
authors.forename: J
authors.initials: J
authors.lastname: Rambeloarisoa
authors.forename: P
authors.initials: P
authors.lastname: Morlat
authors.forename: J-C
authors.initials: JC
authors.lastname: Baste
authors.forename: J
authors.initials: J
authors.lastname: Beylot
mesh_terms: D000328:Adult; D017544:Aortic Aneurysm, Abdominal / Q000209:etiology* / Q000628:therapy; D001528:Behcet Syndrome / Q000097:blood / Q000150:complications* / Q000628:therapy; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications* / Q000628:therapy; D008297:Male; D012851:Sinus Thrombosis, Intracranial / Q000209:etiology* / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D016682:Lupus Coagulation Inhibitor